Your browser doesn't support javascript.
loading
Melanoma-Derived Wnt5a Promotes Local Dendritic-Cell Expression of IDO and Immunotolerance: Opportunities for Pharmacologic Enhancement of Immunotherapy.
Holtzhausen, Alisha; Zhao, Fei; Evans, Kathy S; Tsutsui, Masahito; Orabona, Ciriana; Tyler, Douglas S; Hanks, Brent A.
Affiliation
  • Holtzhausen A; Department of Pharmacology and Cell Biology, Duke University Medical Center, Durham, North Carolina.
  • Zhao F; Department of Medicine, Division of Medical Oncology, Duke University Medical Center, Durham, North Carolina.
  • Evans KS; Department of Medicine, Division of Medical Oncology, Duke University Medical Center, Durham, North Carolina.
  • Tsutsui M; Department of Surgery, Division of Surgical Oncology, Duke University Medical Center, Durham, North Carolina.
  • Orabona C; Department of Experimental Medicine, Section of Pharmacology, University of Perugia, Perugia, Italy.
  • Tyler DS; Department of Surgery, Division of Surgical Oncology, Duke University Medical Center, Durham, North Carolina.
  • Hanks BA; Department of Medicine, Division of Medical Oncology, Duke University Medical Center, Durham, North Carolina. brent.hanks@duke.edu.
Cancer Immunol Res ; 3(9): 1082-95, 2015 Sep.
Article in En | MEDLINE | ID: mdl-26041736

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Dendritic Cells / Proto-Oncogene Proteins / Indoleamine-Pyrrole 2,3,-Dioxygenase / Wnt Proteins / Melanoma Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Cancer Immunol Res Year: 2015 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Dendritic Cells / Proto-Oncogene Proteins / Indoleamine-Pyrrole 2,3,-Dioxygenase / Wnt Proteins / Melanoma Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Cancer Immunol Res Year: 2015 Document type: Article